Fresenius Medical Care AG & Co. KGaA
FMS · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $274,797 | $272,296 | $189,608 | $66,899 |
| Dep. & Amort. | $382,227 | $375,235 | $394,363 | $391,945 |
| Deferred Tax | $0 | -$22,622 | -$30,487 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $38,458 |
| Change in WC | -$278,323 | $281,863 | -$385,024 | $4,517 |
| Other Non-Cash | $362,858 | -$131,842 | -$5,636 | $329,883 |
| Operating Cash Flow | $741,559 | $774,930 | $162,824 | $831,702 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$192,214 | -$154,383 | -$145,760 | -$240,690 |
| Net Acquisitions | -$3,171 | -$8,174 | $12,682 | $18,332 |
| Inv. Purchases | $0 | $167 | -$11,570 | $0 |
| Inv. Sales/Matur. | $0 | $12,457 | $32,942 | $0 |
| Other Inv. Act. | $141,380 | $7,879 | $3,465 | $103,164 |
| Investing Cash Flow | -$54,005 | -$142,054 | -$108,241 | -$119,194 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$669,384 | $547,173 | -$79,009 | -$737,009 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$151,119 | $0 | $0 | $0 |
| Dividends Paid | $0 | -$422,515 | $0 | $0 |
| Other Fin. Act. | -$314,750 | -$45,435 | -$59,779 | -$228,176 |
| Financing Cash Flow | -$1,135,253 | $79,223 | -$138,788 | -$965,185 |
| Forex Effect | -$16,216 | -$70,651 | -$22,434 | $50,793 |
| Net Chg. in Cash | -$463,915 | $641,448 | -$106,639 | -$201,884 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,720,137 | $1,078,689 | $1,185,328 | $1,387,212 |
| End Cash | $1,256,222 | $1,720,137 | $1,078,689 | $1,185,328 |
| Free Cash Flow | $549,345 | $620,547 | $17,064 | $591,012 |